What's Happening?
Johnson & Johnson is actively recruiting for a Senior Manager, Pricing and Access Strategy, to join its China Market Access Center of Excellence team. This role, based in Beijing or Shanghai, is crucial for developing and implementing integrated pricing
and market access strategies across the company's innovative medicine portfolio. The successful candidate will be responsible for maximizing patient access and business value throughout the product lifecycle, including early access assessments for pipelines, launch and National Reimbursement Drug List (NRDL) reimbursement strategy development, and lifecycle management. The position requires deep market access expertise, strategic thinking, strong analytical rigor, and cross-functional leadership to ensure market access considerations are integrated into key business decisions. This strategic hire underscores Johnson & Johnson's commitment to strengthening its presence and optimizing its healthcare solutions in the Chinese market.
Why It's Important?
This recruitment highlights the increasing importance of market access and pricing strategies for pharmaceutical companies operating in the global healthcare landscape, particularly in a significant market like China. The Senior Manager's role is vital for navigating the complexities of China's healthcare system, including the NRDL, which dictates drug reimbursement. Effective pricing and access strategies directly impact the availability and affordability of innovative medicines for patients, while also influencing the company's revenue and market share. By investing in this strategic position, Johnson & Johnson aims to ensure its products reach patients efficiently and sustainably, contributing to public health outcomes and maintaining a competitive edge in a rapidly evolving market. The role's focus on early asset and pipeline access strategy also indicates a long-term vision for future product launches and market penetration.
What's Next?
The successful candidate will be expected to lead the development and management of integrated pricing strategies across assigned therapeutic areas, including new pipeline products, indications, and line extensions. This will involve conducting pricing and payer research, providing strategic recommendations for business planning cycles, and identifying emerging risks and opportunities. The Senior Manager will also partner with local New Product Planning teams and regional pricing and market access teams to shape strategies for pipeline assets, focusing on early access assessments and value optimization. Collaboration with cross-functional teams such as Market Access Strategy, Central Government Affairs, Commercial, Regulatory Affairs, and Finance Business Partners will be essential to ensure alignment and maximize strategic impact. The role will also involve supporting governance discussions and senior management decision-making through data-driven recommendations.
Beyond the Headlines
The creation of such a specialized role reflects a broader trend in the pharmaceutical industry towards more sophisticated and localized market access strategies. As healthcare systems globally become more complex and cost-conscious, the ability to effectively price and secure reimbursement for innovative medicines is paramount. In China, the NRDL plays a critical role in market access, and companies must demonstrate the value of their products to secure favorable inclusion. This position also touches upon ethical considerations regarding equitable access to healthcare, as pricing decisions directly influence patient affordability. The emphasis on cross-functional collaboration and alignment with regional/global policies suggests a holistic approach to market access, recognizing that successful product launches require a coordinated effort across various departments and geographical regions. This strategic investment by Johnson & Johnson could set a precedent for how other multinational pharmaceutical companies approach market access in China.
